Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Allogeneic haemopoietic cell transplant services in Australia and New Zealand in the first year of the COVID-19 pandemic: a report from Australia and New Zealand transplant and cellular therapies.
Othman J, Aarons D, Bajel A, Butler J, Doocey R, O'Brien T, Purtill D, Smith L, Wilcox L, Hamad N. Othman J, et al. Among authors: purtill d. Intern Med J. 2023 Mar;53(3):323-329. doi: 10.1111/imj.15886. Epub 2022 Sep 16. Intern Med J. 2023. PMID: 35833788 Free PMC article.
Acute myeloid leukaemia relapsing after allogeneic haemopoietic stem cell transplantation: prognostic factors and impact of initial therapy of relapse.
Lim ABM, Curley C, Fong CY, Bilmon I, Beligaswatte A, Purtill D, Getta B, Johnston AM, Armytage T, Collins M, Mason K, Fielding K, Greenwood M, Gibson J, Hertzberg M, Wright M, Lewis I, Moore J, Curtis D, Szer J, Kennedy G, Ritchie D. Lim ABM, et al. Among authors: purtill d. Intern Med J. 2018 Mar;48(3):276-285. doi: 10.1111/imj.13522. Intern Med J. 2018. PMID: 28628276
Hematopoietic Stem Cell Transplant Recipients Surviving at Least 2 Years from Transplant Have Survival Rates Approaching Population Levels in the Modern Era of Transplantation.
Kliman D, Nivison-Smith I, Gottlieb D, Hamad N, Kerridge I, Purtill D, Szer J, Ma D. Kliman D, et al. Among authors: purtill d. Biol Blood Marrow Transplant. 2020 Sep;26(9):1711-1718. doi: 10.1016/j.bbmt.2020.03.005. Epub 2020 Mar 16. Biol Blood Marrow Transplant. 2020. PMID: 32194285 Free article.
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease.
Zeiser R, von Bubnoff N, Butler J, Mohty M, Niederwieser D, Or R, Szer J, Wagner EM, Zuckerman T, Mahuzier B, Xu J, Wilke C, Gandhi KK, Socié G; REACH2 Trial Group. Zeiser R, et al. N Engl J Med. 2020 May 7;382(19):1800-1810. doi: 10.1056/NEJMoa1917635. Epub 2020 Apr 22. N Engl J Med. 2020. PMID: 32320566 Clinical Trial.
Bone Marrow Transplant Society of Australia and New Zealand COVID-19 consensus position statement.
Hamad N, Gottlieb D, Ritchie D, Kennedy G, Watson AM, Greenwood M, Doocey R, Perera T, Spencer A, Wong E, O'Brien T, Shaw P, Conyers R, Cole T, Milliken S, Bardy P, Larsen S, Lai H, Butler A, Fraser C, Bajel A, Butler J, Kerridge I, Purtill D. Hamad N, et al. Among authors: purtill d. Intern Med J. 2020 Jun;50(6):774-775. doi: 10.1111/imj.14867. Intern Med J. 2020. PMID: 32537929 Free PMC article. No abstract available.
Australasian Trends in Allogeneic Stem Cell Transplantation for Myelofibrosis in the Molecular Era: A Retrospective Analysis from the Australasian Bone Marrow Transplant Recipient Registry.
Lwin Y, Kennedy G, Gottlieb D, Kwan J, Ritchie D, Szer J, Milliken S, Browett P, Spencer A, Butler A, Bardy P, Greenwood M, Perera T, He S, McEwan A, Larsen S, Lai H, Purtill D, Tran S, Aarons D, Hamad N. Lwin Y, et al. Among authors: purtill d. Biol Blood Marrow Transplant. 2020 Dec;26(12):2252-2261. doi: 10.1016/j.bbmt.2020.08.024. Epub 2020 Aug 27. Biol Blood Marrow Transplant. 2020. PMID: 32861814 Free article.
70 results